Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 15, 2026, titled "Aurobindo Pharma receives USFDA Final Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg".
Aurobindo Pharma Ltd Press Release Sep 15 2026
Filed with NSE · · 3 pages · English
Release
Earlier from Aurobindo Pharma
- Aurobindo Pharma Ltd Press Release Aug 31 2026
- Aurobindo Pharma Ltd Press Release Aug 05 2026
- Aurobindo Pharma Ltd Press Release Jul 24 2026
- Aurobindo Pharma Ltd Press Release Jun 22 2026
- Press Release Jun 04 2026
Later from Aurobindo Pharma
- Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 30, 2026, titled "Acrotech Biopharma Launches ADQUEY in the U.S. and Establishes Dedicated Dermatology Business".
- Aurobindo Pharma Ltd Press Release Sep 30 2026
- Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 03, 2026, titled "Aurobindo Pharma receives USFDA Final Approval for Perampanel Tablets, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg".
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma